All Stories

  1. Pharmacokinetic and bioequivalence study

    Article • Drug Design Development and Therapy, September 2019, Taylor & Francis

    Woo Youl Kang

  2. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects

    Article • Drug Design Development and Therapy, October 2018, Dove Medical Press

    Woo Youl Kang, Boram Ohk

  3. Estrogen-related receptor γ negatively regulates osteoclastogenesis and protects against inflammatory bone loss

    Article • Journal of Cellular Physiology, August 2018, Wiley

    Woo Youl Kang

  4. Pharmacokinetic and bioequivalence study of a telmisartan/S-amlodipine fixed-dose combination (CKD-828) formulation and coadministered telmisartan and S-amlodipine in healthy subjects

    Article • Drug Design Development and Therapy, March 2018, Dove Medical Press

    Woo Youl Kang, Boram Ohk

  5. G protein-coupled receptor 84 controls osteoclastogenesis through inhibition of NF-κB and MAPK signaling pathways

    Article • Journal of Cellular Physiology, July 2017, Wiley

    Woo Youl Kang